Please wait

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Pacitti David (Last) (First) (Middle) 5405 WINDWARD PKWY (Street) ALPHARETTA GA 30004 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 04/14/2025	3. Issuer Name and Ticker or Trading Symbol AVANOS MEDICAL, INC. [ AVNS ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Executive Officer	5. If Amendment, Date of Original Filed (Month/Day/Year) 04/24/2025
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	242,047(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance-based restricted stock unit	04/14/2028	04/14/2028	Common Stock	242,047(2)	$0	D

Explanation of Responses:

1. Represents time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended (the Plan). The award will vest 30% on April 14, 2026, 30% on April 14, 2027 and 40% on April 14, 2028; provided that if the Reporting Person is terminated without Cause (as defined in the Plan), the TRSUs will vest in full. Each TRSU is the economic equivalent of one share of Common Stock.

2. Represents performance-based restricted share units (PRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. Such PRSUs will vest on April 14, 2028 (the PRSU Vesting Date) and will pay out: (i) at 50% of the number of PRSUs if the price of the Common Stock on the PRSU Vesting Date is $20.00; (ii) at 100% of the number of PRSUs if the price of the Common Stock on the PRSU Vesting Date is $25.00; (iii) at 200% of the number of PRSUs if the price of the Common Stock on the PRSU Vesting Date is $29.00; and (iv) at 250% of the number of PRSUs if the price of the Common Stock on the PRSU Vesting Date is $33.00 or higher. Each PRSU is the economic equivalent of one share of Common Stock.

Remarks:

This Form 3/A is being filed to clarify that the TRSUs described in footnote 1 are subject to accelerated vesting in certain circumstances.

	/s/ Mojirade James, as attorney-in-fact for David Pacitti	04/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.